The team at Trilegal provides a comprehensive healthcare and life sciences offering, working on digital health care solutions and medical devices. The group is well equipped to handle public and private M&A transactions in this sphere. Alongside this, it routinely advises clients on navigating regulatory and compliance matters, with experience in cross-border cases. Harsh Maggon, who has notable expertise in advising foreign investors, and Kosturi Ghosh, who routinely advises on regulatory compliance, are key contacts, as is Nishant Parikh.
Legal 500 Editorial commentary

Key clients

  • Platinum Equity LLC
  • Blackstone, Quality Care India Limited
  • Viyash Life Sciences Private Limited
  • Sahyadri Hospitals Private Limited
  • Maiva Pharma Private Limited
  • InHealth Ventures GP LLP
  • Dr. Manish Shantilal Shah – Foresight Eye Centre
  • Goldman Sachs and its affiliates
  • Nephrocare Health Services Private Limited
  • Health Data Specialists Ireland Limited
  • Blackstone
  • Balloon Healthcare Private Limited
  • NHPEA V Star (BVI) Limited
  • Copilot, Inc.,
  • Pandorum Technologies Private Limited
  • Senores Pharmaceuticals Limited
  • Indira IVF Hospital Limited
  • Manipal Group
  • Eight Roads Investment Advisors Private Limited

Work highlights

Advising Platinum Equity, a US-based private equity fund, on the acquisition of a majority stake in Inventia Healthcare Limited (Inventia), a Mumbai-based pharmaceutical company engaged in the business of manufacturing and sale of solid oral dosage drugs.
Advising on the merger of QCIL with and into Aster DM Healthcare Limited (Aster), and related share acquisitions.
Advised Viyash Life Sciences Private Limited, its group companies (collectively, Viyash Group Entities), its founders and promoters on the merger of the Viyash Group Entities, Sequent Research Limited (a wholly owned subsidiary of Sequent Scientific Limited) with Sequent Scientific Limited (Sequent), an Indian listed company.

Other key lawyers

Harsh Maggon; Kosturi Ghosh; Nishant Parikh